| 1 |
Delaney G, Jacob S, Featherstone C, et al. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines [J]. Cancer, 2005,104(6): 1129-1137.
|
| 2 |
Hanna TP, Shafiq J, Delaney GP, et al. The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits [J]. Radiother Oncol, 2018,126(2): 191-197.
|
| 3 |
Grimes DR. Radiofrequency radiation and cancer: a review [J]. JAMA Oncol, 2022,8(3): 456-461.
|
| 4 |
Shi X, Yang J, Deng S, et al. TGF-beta signaling in the tumor metabolic microenvironment and targeted therapies [J]. J Hematol Oncol, 2022,15(1): 135.
|
| 5 |
Reisländer T, Groelly FJ, Tarsounas M. DNA Damage and Cancer Immunotherapy: A sting in the tale [J]. Mol Cell, 2020,80(1): 21-28.
|
| 6 |
Barcellos-Hoff MH, Cucinotta FA. New tricks for an old fox: impact of TGFβ on the DNA damage response and genomic stability [J]. Sci Signal, 2014,7(341): re5.
|
| 7 |
Shiloh Y. ATM and related protein kinases: safeguarding genome integrity [J]. Nat Rev Cancer, 2003,3(3): 155-168.
|
| 8 |
Li Y, Liu Y, Chiang YJ, et al. DNA damage activates TGF-β signaling via ATM-c-Cbl-mediated stabilization of the type II receptor TβRII [J]. Cell Rep, 2019,28(3): 735-745.
|
| 9 |
Kirshner J, Jobling MF, Pajares MJ, et al. Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress [J]. Cancer Res, 2006,66(22): 10861-10869.
|
| 10 |
Kciuk M, Bukowski K, Marciniak B, et al. Advances in DNA repair-emerging players in the arena of eukaryotic DNA repair [J]. Int J Mol Sci, 2020,21(11):3934.
|
| 11 |
Centurione L, Aiello FB. DNA repair and cytokines: TGF-β, IL-6, and thrombopoietin as different biomarkers of radioresistance [J]. Front Oncol, 2016,6: 175.
|
| 12 |
Liang S, Thomas SE, Chaplin AK, et al. Structural insights into inhibitor regulation of the DNA repair protein DNA-PKcs [J]. Nature, 2022,601(7894): 643-648.
|
| 13 |
Ramu AK, Ali D, Alarifi S, et al. Reserpine inhibits DNA repair, cell proliferation, invasion and induces apoptosis in oral carcinogenesis via modulation of TGF-β signaling [J]. Life Sci, 2021,264: 118730.
|
| 14 |
Dai L, Dai Y, Han J, et al. Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin [J]. Mol Cell, 2021,81(13): 2765-2777.
|
| 15 |
Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer [J]. Signal Transduct Target Ther, 2020,5(1): 60.
|
| 16 |
Kang SH, Bak DH, Chung BY, et al. Centipedegrass extract enhances radiosensitivity in melanoma cells by inducing G2/M cell cycle phase arrest [J]. Mol Biol Rep, 2021,48(2): 1081-1091.
|
| 17 |
Reynisdóttir I, Polyak K, Iavarone A, et al. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta [J]. Genes Dev, 1995,9(15): 1831-1845.
|
| 18 |
Derynck R, Budi EH. Specificity, versatility, and control of TGF-β family signaling [J]. Sci Signal, 2019,12(570): eaav5183.
|
| 19 |
Subbarayan K, Massa C, Lazaridou M F, et al. Identification of a novel miR-21-3p/TGF-beta signaling-driven immune escape via the MHC class I/biglycan axis in tumor cells [J]. Clin Transl Med, 2021,11(3): e306.
|
| 20 |
Lee YJ, Han Y, Lu HT, et al. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression [J]. J Immunol, 1997,158(5): 2065-2075.
|
| 21 |
Du F, Qi X, Zhang A, et al. MRTF-A-NF-κB/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-β [J]. Exp Mol Med, 2021,53(9): 1366-1378.
|
| 22 |
Gorelik L, Flavell RA. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells [J]. Nat Med, 2001,7(10): 1118-1122.
|
| 23 |
Sun X, Cui Y, Feng H, et al. TGF-beta signaling controls Foxp3 methylation and T reg cell differentiation by modulating Uhrf1 activity [J]. J Exp Med, 2019,216(12): 2819-2837.
|
| 24 |
Lainé A, Labiad O, Hernandez-Vargas H, et al. Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation [J]. Nat Commun, 2021,12(1): 6228.
|
| 25 |
Zhang F, Wang H, Wang X, et al. TGF-beta induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype [J]. Oncotarget, 2016,7(32): 52294-52306.
|
| 26 |
李旭, 黄尚科, 王玉珍, 等. 乳腺癌组织肿瘤相关巨噬细胞与肿瘤浸润转移的临床及病理关系[J/OL]. 中华临床医师杂志(电子版), 2017,11(18): 2217-2222.
URL
|
| 27 |
张琪悦, 王晓东. IL-8与肿瘤免疫的研究进展 [J/OL]. 中华临床医师杂志(电子版), 2023,17(5): 605-613.
|
| 28 |
李晓梅, 叶红, 秦书明, 等. TMPRSS4通过上皮间质转化促进乳腺癌细胞的增殖、侵袭和转移[J/OL]. 中华临床医师杂志(电子版), 2018,12(5): 279-287.
|
| 29 |
Feng F, Zhao Z, Cai X, et al. Cyclin-dependent kinase subunit2 (CKS2) promotes malignant phenotypes and epithelial-mesenchymal transition-like process in glioma by activating TGFβ/SMAD signaling [J]. Cancer Med, 2023,12(5): 5889-5907.
|
| 30 |
Ebert MS, Neilson JR, Sharp PA. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells [J]. Nat Methods, 2007,4(9): 721-726.
|
| 31 |
Su Y, Feng W, Shi J, et al. circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway [J]. Mol Cancer, 2020,19(1): 23.
|
| 32 |
Esposito M, Fang C, Cook KC, et al. TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis [J]. Nat Cell Biol, 2021,23(3): 257-267.
|
| 33 |
Chen X, Yan N. Stachydrine inhibits TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-β/Smad and PI3K/Akt/mTOR signaling pathways [J]. Anticancer Drugs, 2021,32(8): 786-792.
|
| 34 |
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition [J]. Nat Rev Mol Cell Biol, 2014,15(3): 178-196.
|
| 35 |
Liu Y, He K, Hu Y, et al. YAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor [J]. Sci Rep, 2017,7: 45523.
|
| 36 |
Hao Y, Baker D, Ten D P. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis [J]. Int J Mol Sci, 2019,20(11): 2767.
|
| 37 |
Xue G, Restuccia DF, Lan Q, et al. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes [J]. Cancer Discov, 2012,2(3): 248-259.
|
| 38 |
刘蔚, 祝训浩, 王修竹. TGF-β促进胰腺癌发展的相关研究进展 [J]. 临床医学进展, 2022,12(12): 11405-11411.
|
| 39 |
庄乾伟, 刘广龙, 王丽珍, 等. 转TGF-β1基因小鼠体内放疗敏感性初步评价 [J]. 中国口腔颌面外科杂志, 2013,11(3): 183-191.
|
| 40 |
Aubrey BJ, Kelly GL, Janic A, et al. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? [J]. Cell Death Differ, 2018,25(1): 104-113.
|
| 41 |
Wei H, Wang H, Wang G, et al. Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity [J]. Nat Commun, 2023,14(1): 4300.
|
| 42 |
Brentnall M, Rodriguez-Menocal L, De Guevara RL, et al. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis [J]. BMC Cell Biol, 2013,14: 32.
|
| 43 |
Sheikh MS, Fornace AJ. Death and decoy receptors and p53-mediated apoptosis [J]. Leukemia, 2000,14(8): 1509-1513.
|
| 44 |
Ahmed MM, Alcock RA, Chendil D, et al. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2 [J]. J Biol Chem, 2002,277(3): 2234-2246.
|
| 45 |
Shi X, Yang J, Deng S, et al. TGF-β signaling in the tumor metabolic microenvironment and targeted therapies [J]. J Hematol Oncol, 2022,15(1): 135.
|
| 46 |
Zhang Q, Yu N, Lee C. Mysteries of TGF-beta paradox in benign and malignant cells [J]. Front Oncol, 2014,4: 94.
|
| 47 |
Madhav A, Andres A, Duong F, et al. Antagonizing CD105 enhances radiation sensitivity in prostate cancer [J]. Oncogene, 2018,37(32): 4385-4397.
|
| 48 |
Konge J, Leteurtre F, Goislard M, et al. Breast cancer stem cell-like cells generated during TGFβ-induced EMT are radioresistant [J]. Oncotarget, 2018,9(34): 23519-23531.
|
| 49 |
Ehrhart EJ, Segarini P, Tsang ML, et al. Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation [J]. FASEB J, 1997,11(12): 991-1002.
|
| 50 |
Park SH, Kim JY, Kim JM, et al. PM014 attenuates radiation-induced pulmonary fibrosis via regulating NF-kB and TGF-b1/NOX4 pathways [J]. Sci Rep, 2020,10(1): 16112.
|
| 51 |
Ying H, Fang M, Hang QQ, et al. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway [J]. J Cell Mol Med, 2021,25(18): 8662-8675.
|
| 52 |
Tang Y, Yuan Q, Zhao C, et al. Targeting USP11 may alleviate radiation-induced pulmonary fibrosis by regulating endothelium tight junction [J]. Int J Radiat Biol, 2022,98(1): 30-40.
|
| 53 |
Zhen S, Qiang R, Lu J, et al. TGF-β1-based CRISPR/Cas9 Gene Therapy Attenuates Radiation-induced Lung Injury [J]. Curr Gene Ther, 2022,22(1): 59-65.
|
| 54 |
胡蝶. TGF-β3通过上皮间质转化抑制放射性肺纤维化及其机制研究 [D]. 广东药科大学, 2018.
|
| 55 |
Santibanez JF, Obradovic H, Kukolj T, et al. Transforming growth factor-beta, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition [J]. Dev Dyn, 2018,247(3): 382-395.
|
| 56 |
Broxmeyer H E. Associated guilt: radiation/bystanders[J]. Blood,2021,137(24):3314-3316.
|
| 57 |
Zhang J, Yao D, Zhang J, et al. TGF-β mediates thoracic radiation-induced abscopal effects of testis injury in rat [J]. Biochem Biophys Res Commun, 2019,514(3): 678-683.
|
| 58 |
Zhang YM, Zhang LY, Li YY, et al. Radiation-induced bystander effect on the genome of bone marrow mesenchymal stem cells in lung cancer [J]. Antioxid Redox Signal, 2023,38(10-12): 747-767.
|
| 59 |
Gu J, Sun Y, Song J, et al. Irradiation induces DJ-1 secretion from esophageal squamous cell carcinoma cells to accelerate metastasis of bystander cells via a TGF-β1 positive feedback loop [J]. J Exp Clin Cancer Res, 2022,41(1): 259.
|
| 60 |
Rodrigues-Junior DM, Tan SS, Lim SK, et al. Circulating extracellular vesicle-associated TGFbeta3 modulates response to cytotoxic therapy in head and neck squamous cell carcinoma [J]. Carcinogenesis, 2019,40(12): 1452-1461.
|
| 61 |
Schirmer MA, Mergler CP, Rave-Frank M, et al. Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant [J]. Int J Radiat Oncol Biol Phys, 2012,83(1): 149-157.
|
| 62 |
Mortensen R, Holmstrom MO, Lisle TL, et al. Pre-existing TGF-beta-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy [J]. J Immunother Cancer, 2023,11(3): e006432.
|
| 63 |
Reuther S, Szymczak S, Raabe A, et al. Association between SNPs in defined functional pathways and risk of early or late toxicity as well as individual radiosensitivity [J]. Strahlenther Onkol, 2015,191(1): 59-66.
|
| 64 |
Anscher MS, Marks LB, Shafman TD, et al. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation [J]. J Clin Oncol, 2001,19(17): 3758-3765.
|
| 65 |
Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity [J]. Cancer Res, 2003,63(24): 8717-8725.
|
| 66 |
Grossberg AJ, Lei X, Xu T, et al. Association of transforming growth factor beta polymorphism C-509T with radiation-induced fibrosis among patients with early-stage breast cancer: A secondary analysis of a randomized clinical trial [J]. JAMA Oncol, 2018,4(12): 1751-1757.
|
| 67 |
Bentzen SM, Skoczylas JZ, Overgaard M, et al. Radiotherapy-related lung fibrosis enhanced by tamoxifen [J]. J Natl Cancer Inst, 1996,88(13): 918-922.
|
| 68 |
Yamazaki T, Gunderson AJ, Gilchrist M, et al. Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial [J]. Lancet Oncol, 2022,23(9): 1189-1200.
|
| 69 |
Wick A, Desjardins A, Suarez C, et al. Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma [J]. Invest New Drugs, 2020,38(5): 1570-1579.
|
| 70 |
Formenti SC, Lee P, Adams S, et al. Focal irradiation and systemic TGFbeta blockade in metastatic breast cancer [J]. Clin Cancer Res, 2018,24(11): 2493-2504.
|
| 71 |
Murphy JE, Wo JY, Ryan DP, et al. Total neoadjuvant therapy with Folfirinox in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: A phase 2 clinical trial [J]. JAMA Oncol, 2019,5(7): 1020-1027.
|